Healthcare Contract Research Outsourcing Market Size, Share, Trends, Growth and Forecast 2032

Healthcare Contract Research Outsourcing Market Insights

Zion Market Research has published a report on the global Healthcare Contract Research Outsourcing Market, estimating its value at USD 47.46 Billion in 2023, with projections indicating that it will reach USD 84.36 Billion by 2032. The market is expected to expand at a compound annual growth rate (CAGR) of 6.6% over the forecast period 2024-2032.

The report explores the factors fueling market growth, the hitches that could hamper this expansion, and the opportunities that may arise in the Healthcare Contract Research Outsourcing Market industry. Additionally, it offers a detailed analysis of how these elements will affect market demand dynamics and market performance throughout the forecast period.

Request Free Sample

Global Healthcare Contract Research Outsourcing Market: Overview

In Global Healthcare Contract Research Outsourcing Market Report,A Clinical Research Organization (CRO) is a service organization offering support in the form of outsourced pharmaceutical testing services to the pharmaceutical and biotechnology industries (for medical and drug devices). CROs vary from large, international full-service companies to small, local specialty groups and can provide their consumers the experience of moving a new drug or product from its conception to marketing approval by the Food and Drug Administration (FDA) without having to retain a workforce for these services by the drug sponsor.

While the CRO industry has been around for decades, it is rising substantially more than ever since the rivalry between organizations is increasing and the need for outsourced clinical services is growing. As the drug manufacturing process becomes more and more complex, all the tools required to make the process more efficient are being used by the pharmaceutical industry.

Request Free Sample

Global Healthcare Contract Research Outsourcing Market: Growth Factors

Healthcare providers often outsource drug manufacturing functions to CROs to use development capabilities globally, effectively, and efficiently. CROs' clinical, therapeutic, and regulatory insight aims to strengthen the full production cost and speed up the time to look out for a new product. CROs have grown broader and vastly more diversified across numerous therapeutic functions and areas, extending their penetration. CROs are expected to grow globally and add competencies in new therapeutic areas, thus boosting their current services beyond conventional clinical capabilities, including commercial, post-approval, and informatics among other auxiliary offerings where low outsourced penetration has been observed, further growing demand for CROs, and driving increased outsourcing demand.

The healthcare contract research outsourcing market is expected to witness significant growth during the forecast period, driven by increased investment from small to medium-sized companies in pharmaceutical, medical devices, and biotechnology that will lead organizations to opt for CRO services, with attention to a niche market. Small pharmaceutical firms are looking for innovations in the production process through CRO services due to increased demand for new drugs and patent expiry. Outsourcing also enhances global scope with respect to drug production at low maintenance costs, as CROs are well aligned with regulatory criteria in different regions to boost the growth of the outsourcing market for healthcare contract research.

Impact due to the outbreak of COVID-19

The outbreak of COVID-19 has impacted the different functions of the healthcare sector. With the review of the clinical trial database and taking into account the functioning of key players on the CROs market, it has been observed that the growth of the CROs market has been hampered during 2019-2020. This epidemic has put a massive burden on the pharmaceutical industry to manufacture vaccines, diagnostic assays and breakthrough drugs. The outbreak of the disease affected 208 countries with 2,000-5,000 new cases every day and redirected the focus of the healthcare industry solely to diagnosis and treatment of COVID-19.

As a result, previously planned and ongoing R&D and clinical trial programs have been suspended or interrupted and the number of clinical trials has declined over the last few months. As per the Clinical Trials Online Magazine, the number of clinical trials in June 2020 was 1,210, down to 1,180 in August 2020. Most investors concentrate on research and development of COVID-19 medicines. Moreover, the expected or ongoing contract-based clinical trial activities and research and development are lagging behind due to delay of registrations, slow initializations, and lack of funding for non-COVID-19 drugs.

GlobalHealthcare Contract Research OutsourcingMarket: Segmentation

On the basis of services, the global market is categorized into clinical trial services, clinical data management & biometrics, pharmacovigilance, regulatory services, medical writing, site management protocol, and others. The most popular outsourced services rendered by healthcare firms are clinical trials, due to the globalization of clinical trials and the lack of therapeutic experience in the unexplored niche market for new drug growth. However, due to the increased strictness of regulatory bodies, complex regulatory processes and changing regulatory criteria, the outsourcing of regulatory services is increasing. Due to increased monitoring by regulatory bodies such as the FDA and European Medicines Agency (EMA) at every step of clinical trial and changing regulatory standards according to the region, the outsourcing of regulatory services is expected to increase.

By therapeutic area, the global healthcare contract research outsourcing is categorized into oncology/hematology, CNS, respiratory, immunology, CV/metabolic, rare diseases, infectious diseases, and others. The oncology/hematology therapeutic category is expected to lead the market in terms of revenue in the coming years, due to factors such as enormous unmet treatment needs, a strong product pipeline, intensified competition and rising oncology incidence. The multiple benefits available by outsourcing of oncology/hematology related services have led to a key segment share in the global market.

GlobalHealthcare Contract Research OutsourcingMarket:Regional Analysis

By Geography, the healthcare contract research outsourcing market is segmented into North America, Europe, Latin America, Asia Pacific, and Middle East and Africa.

North America has dominated the global market and is expected to lose marginally its market share in the coming years. The demand in North America is mainly powered by advanced clinical research site facilities and effective government incentive schemes in the United States. In addition, expanded access to advanced technology and therapeutic knowledge is expected to fuel the growth of clinical trial services in the United States during the forecast period.

In Europe, the rise in the demand for healthcare contract research organizations' services is mainly due to the growing number of clinical trials and increased spending on research and development and outsourcing activities. Factors such as rigid drug approval laws impede the development of the market. In addition, the growing demand for biosimilars and biologics and the development of research technology are likely to accelerate the growth of the healthcare contract research services market during the forecast period.

Asia Pacific is expected to be the most lucrative market for healthcare contract research outsourcing with the maximum attractiveness index. The market in the Asia-Pacific region is expected to grow at a fastest rate during the forecast period. The large patient population in emerging countries such as China and India, firmly-established data integrity regulations and strong healthcare IT budgets in countries such as Taiwan, Japan, Malaysia, South Korea, Singapore, etc., are the factors driving market demand in Asia Pacific. The Latin American market is set to expand at a moderate growth rate during the forecast period.

To know more about this report, Request a FREE sample copy

Healthcare Contract Research Outsourcing Market: Report Scope

GlobalHealthcare Contract Research OutsourcingMarket: Competitive Players

The major players in the global healthcare contract research outsourcing market include -

• Syneos Health
• PRA Health Sciences
• IQVIA
• ICON PLC
• PAREXEL International
• Laboratory Corporation of America Holdings
• Medpace
• Charles River
• Pharmaceutical Product Development
• LLC
• among others.

The report segment of the global healthcare contract research outsourcing market is as follows:

Global Healthcare Contract Research Outsourcing Market: Service Segment Analysis

• Clinical Trial Services
• Clinical Data Management & Biometrics
• Pharmacovigilance
• Regulatory Services
• Medical Writing
• Site Management Protocol
• Others

Global Healthcare Contract Research Outsourcing Market: Therapeutic Area Segment Analysis

• Oncology/Hematology
• Respiratory
• Central Nervous System (CNS)
• Cardiovascular (CV)/Metabolic
• Rare Diseases
• Infectious Diseases
• Immunology
• Others

Global Healthcare Contract Research Outsourcing Market: End-User Segment Analysis

• Pharmaceutical Companies
• Medical Devices
• Biotechnology Companies
• Government Organizations
• Academic Institutes

Global Healthcare Contract Research Outsourcing Market: Regional Segment Analysis

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa